The meeting is scheduled for Saturday, November 14, 2026, at 4:00 P.M.
The agenda for the meeting includes:
- Consideration and approval of the Standalone and Consolidated Financial Results for the half year ended September 30, 2026, along with the Auditor's Limited Review Report thereon.
- Consideration and approval of raising funds through the issue of equity shares, warrants, or convertible instruments on a preferential basis to persons identified by the Board.
- Consideration of any other business with the permission of the chair.
The company has confirmed that the trading window for dealing in securities of the company was already closed after intimation to BSE and shall remain closed until 48 hours after the declaration of the financial results for the half year ended September 30, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, including amendments thereto.
Financial Impact
Financial impact of the fundraising proposal will be determined post-board approval and is not quantified in this disclosure.